Emerging Treatment Options in Inflammatory Bowel Disease

Nov 23, 2020 | health and medicine, Karger Publishers

In Collaboration With

Original Article Reference

This SciPod is a shortened and simplified summary of ‘Emerging Treatment Options in Inflammatory Bowel Disease’, published by Karger Publishers https://doi.org/10.1159/000507782

The complete original works are available at www.karger.com

About this episode

Inflammatory bowel disease (IBD) is a group of gastrointestinal conditions affecting almost 7 million people globally, and this incidence is rising. While treatments have improved over the last century, many patients do not respond sufficiently, especially those with moderate to severe levels of the disease. Novel drugs that restrain the immune system and reduce inflammation are being developed with the hope of improving patient outcomes. Dr Benjamin Misselwitz at Island Hospital of Bern and Bern University and his colleagues have conducted a comprehensive review of the emerging therapies and make recommendations for improving treatment for a wider range of patients.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Related episodes

Prof. Elizabeth Regan | The Healthcare Revolution That Technology Alone Cannot Deliver

Prof. Elizabeth Regan | The Healthcare Revolution That Technology Alone Cannot Deliver

Imagine a patient with several health problems moving through a modern medical system. She may see a family doctor, a specialist, a hospital team, a pharmacist and perhaps a community service. Each professional may be highly skilled. Each organisation may own sophisticated software. Yet the patient can still find herself repeating the same story, carrying information between appointments, waiting for records to arrive and trying to understand who is responsible for what. The individual parts work well, but the journey doesn’t.

Dr Sarah Davies – Dr Clare French | The Vaccine Uptake Recipe: Which Ingredients Work for Different Groups?

Dr Sarah Davies – Dr Clare French | The Vaccine Uptake Recipe: Which Ingredients Work for Different Groups?

Vaccines can prevent serious illness, disability and death, but their benefits depend on people actually receiving them. When vaccination rates fall, the usual question is how to support more people to get vaccinated. Yet that question may be too simple. A reminder, a conversation, a financial incentive or a more convenient clinic can all help, but they do not necessarily help everyone in the same way. That is the central insight emerging from a major analysis led by Dr Sarah Davies and Dr Clare French, both of the University of Bristol, and colleagues. To go beyond asking whether broad categories such as “education” or “improved access” work, the researchers took apart vaccine uptake interventions to examine their individual ingredients. It is a little like studying recipes: knowing that a cake tastes good is useful, but knowing which ingredients make the difference is far more helpful if you want to create a better cake.

Prof. Toine Pieters | The Depression Spiral: Rethinking an Illness That Refuses to Stand Still

Prof. Toine Pieters | The Depression Spiral: Rethinking an Illness That Refuses to Stand Still

What if depression is best understood as a process that gathers momentum, rather than a fixed illness that simply appears once enough symptoms have accumulated? A difficult week becomes persistent stress. Persistent stress demands more coping. Coping becomes exhausting. Sleep, appetite, activity and relationships begin to change. Those changes can then create fresh stress, pushing a person further down a self-reinforcing spiral.

Dr. Linda Mermelstein | When Knowledge Is Not Enough: Building Trust Around Prostate Cancer

Dr. Linda Mermelstein | When Knowledge Is Not Enough: Building Trust Around Prostate Cancer

For many men, a conversation about prostate cancer begins long before they enter a doctor’s office. It may begin when a brother mentions a test, when a friend describes a frightening diagnosis, or when a family member dies from cancer. For Black men, those conversations carry particular urgency. Prostate cancer affects them much more often, yet knowing that a disease is dangerous does not automatically mean people have the information, confidence, or trusted relationships needed to make decisions about screening.